PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 5, 2026Nature Communications3 citationsOpen Access

An interpretable AI system reduces false-positive MRI diagnoses by stratifying high-risk breast lesions

View Full Paper
YLYanting LiangZWZhitao WeiDYDai Yi

Key Points

  • The research aims to reduce false-positive MRI diagnoses of breast lesions, improving diagnostic accuracy.
  • Developed the BI-RADS 4 Lesions Analysis System (BL4AS) using a multicenter dataset of 2,803 lesions.
  • Utilized spatiotemporal information from dynamic contrast-enhanced MRI.
  • Compared BL4AS performance against radiologists, measuring specificity and inter-reader variability.
  • BL4AS achieved areas under the curve of 0.892-0.930.
  • Demonstrated higher specificity compared to radiologists (0.889 vs 0.491).
  • Reduced inter-reader variability by 24.5% and lowered false-positive rates by 27.3%.

Abstract

Breast cancer diagnosis using magnetic resonance imaging remains limited by high false-positive rates and substantial inter-reader variability, especially for lesions classified as Breast Imaging Reporting and Data System (BI-RADS) category 4, often leading to unnecessary biopsies. Here we show that the BI-RADS 4 Lesions Analysis System (BL4AS), an artificial intelligence system powered by foundation models and leveraging the rich spatiotemporal information of dynamic contrast-enhanced MRI, addresses these diagnostic challenges. Developed on a multicenter dataset of 2,803 lesions from 2,686 female patients, BL4AS demonstrates robust performance with areas under the curve of 0.892-0.930 and significantly outperforms radiologists in specificity (0.889 versus 0.491). BL4AS-assisted interpretation significantly improves diagnostic accuracy for both senior and junior radiologists, reducing inter-reader variability by 24.5% and decreasing false-positive rates by 27.3%. BL4AS further stratifies lesions into subcategories (4 A, 4B and 4 C) for refined risk assessment, offering a practical tool for precision breast cancer management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liang et al. (2026) studied this question.

synapsesocial.com/papers/698434f9f1d9ada3c1fb3c90https://doi.org/10.1038/s41467-026-69212-7
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Artificial intelligence in healthcare: past, present and future2017 · 4,858 citations
  2. 2A whole-slide foundation model for digital pathology from real-world data2024 · 813 citations
  3. 3Breast Image Analysis for Risk Assessment, Detection, Diagnosis, and Treatment of Cancer2013 · 211 citations
  4. 4Clinical artificial intelligence quality improvement: towards continual monitoring and updating of AI algorithms in healthcare2022 · 413 citations
  5. 5Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI2022 · 530 citations